Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.

BACKGROUND Pharmacological and postmortem investigations suggest that patients with major depressive disorder have alterations in function or density of brain serotonin1A (5-HT1A) receptors. The aim of the present study was to use positron emission tomography with the selective 5-HT1A receptor antagonist [11C]WAY-100635 to measure 5-HT1A receptor binding in depressed patients before and during treatment with selective serotonin reuptake inhibitors. METHODS Positron emission tomographic scans with [11C]WAY-100635 were performed on 25 patients with major depressive disorder. These included 15 unmedicated depressed patients. Ten of these unmedicated patients were scanned again during selective serotonin reuptake inhibitor treatment. A further 10 patients with major depressive disorder were scanned on one occasion only while taking selective serotonin reuptake inhibitors. Comparisons were made with [11C]WAY-100635 positron emission tomographic scans in 18 healthy volunteer subjects. Region of interest analysis and statistical parametric mapping were performed on binding potential images generated using a reference tissue model. RESULTS Binding potential values were reduced across many of the regions examined, including frontal, temporal, and limbic cortex in both unmedicated and medicated depressed patients compared with healthy volunteers. Binding potential values in medicated patients were similar to those in unmedicated patients. CONCLUSIONS Major depressive disorder is associated with a widespread reduction in 5-HT1A receptor binding. This reduced 5-HT1A receptor binding was not changed by selective serotonin reuptake inhibitor treatment.

[1]  R. Spitzer.  Dsm-IV Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition , 1994 .

[2]  P. Cowen,et al.  Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity , 1997, Psychopharmacology.

[3]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[4]  C. de Montigny,et al.  Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression , 1987, Journal of clinical psychopharmacology.

[5]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P A Sargent,et al.  Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.

[7]  H. Meltzer,et al.  Serotonin Receptors in Suicide Victims with Major Depression , 1997, Neuropsychopharmacology.

[8]  K. Lesch.  5-HT1A receptor responsivity in anxiety disorders and depression. , 1991, Progress in neuro-psychopharmacology & biological psychiatry.

[9]  G. Rajkowska,et al.  Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.

[10]  S. Svebak,et al.  Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. , 1990, The Journal of clinical psychiatry.

[11]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[12]  C. Katona,et al.  5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. , 1997, Journal of affective disorders.

[13]  J. John Mann,et al.  Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.

[14]  J. Kleinman,et al.  Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics , 1993, Neuropsychopharmacology.

[15]  J. Marcusson,et al.  Brain 5-HT1A, 5-HT1D, and 5-HT2 Receptors in suicide victims , 1994, Biological Psychiatry.

[16]  C. Montigny,et al.  Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment , 1989, Synapse.

[17]  L. D. van de Kar,et al.  Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats , 1994, Biological Psychiatry.

[18]  T. Spinks,et al.  Correction for scatter in 3D brain PET using a dual energy window method. , 1996, Physics in medicine and biology.

[19]  G. Goodwin,et al.  Functional imaging, affective disorder and dementia. , 1996, British medical bulletin.

[20]  Roger N. Gunn,et al.  Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.

[21]  A. Honig,et al.  Depression : neurobiological, psychopathological, and therapeutic advances , 1997 .

[22]  G. Aghajanian,et al.  Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. , 1978, Science.

[23]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[24]  Paul Kinahan,et al.  Analytic 3D image reconstruction using all detected events , 1989 .

[25]  P. Cowen,et al.  5-HT1A Receptor Sensitivity in Major Depression , 1994, British Journal of Psychiatry.

[26]  Ralph Myers,et al.  Assessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates , 1999, NeuroImage.

[27]  K. Lesch.  5-HT1A receptor responsivity in anxiety disorders and depression , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[29]  L. D. van de Kar,et al.  A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. , 1997, The Journal of pharmacology and experimental therapeutics.

[30]  Anat Biegon,et al.  Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.

[31]  L. D. van de Kar,et al.  Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. , 1996, The Journal of pharmacology and experimental therapeutics.

[32]  Victor W. Pike,et al.  Remotely-controlled production of the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635, via 11C-carboxylation of an immobilized Grignard reagent , 1996 .

[33]  I. Ferrier,et al.  5-HT1A Receptors in major depression , 1990, Journal of psychopharmacology.

[34]  J. Hensler,et al.  A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[35]  C. de Montigny,et al.  A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. , 1990, The Journal of clinical psychiatry.

[36]  M E Raichle,et al.  Neuroanatomical circuits in depression: implications for treatment mechanisms. , 1992, Psychopharmacology bulletin.

[37]  S. Haj-Dahmane,et al.  Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. , 1994, The Journal of pharmacology and experimental therapeutics.

[38]  J. Deakin,et al.  5 -HT, antidepressant drugs and the psychosocial origins of depression , 1996, Journal of psychopharmacology.

[39]  H. Meltzer,et al.  Effects of ipsapirone on plasma cortisol and body temperature in major depression , 1995, Biological Psychiatry.